Similar to the effect of lj‐2‐66 in melanoma cells, it has been demonstrated that glucocorticoid receptor‐mediated signalling exerts a significant impact on breast cancer cells, increasing intracellular levels of ROS and DNA damage and negatively affecting repair processes. This evidence concerns the gene NR3C1 and breast cancer.